116 related articles for article (PubMed ID: 14978752)
1. Toolbox for retrovectorologists.
Pagès JC; Bru T
J Gene Med; 2004 Feb; 6 Suppl 1():S67-82. PubMed ID: 14978752
[TBL] [Abstract][Full Text] [Related]
2. Safety features of retroviral vectors.
Hansen AC; Pedersen FS
Curr Opin Mol Ther; 2002 Aug; 4(4):324-33. PubMed ID: 12222870
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
Sinn PL; Sauter SL; McCray PB
Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
[TBL] [Abstract][Full Text] [Related]
4. Intracellular trafficking of retroviral vectors: obstacles and advances.
Anderson JL; Hope TJ
Gene Ther; 2005 Dec; 12(23):1667-78. PubMed ID: 16292352
[TBL] [Abstract][Full Text] [Related]
5. Retroviral vectors: new applications for an old tool.
Barquinero J; Eixarch H; Pérez-Melgosa M
Gene Ther; 2004 Oct; 11 Suppl 1():S3-9. PubMed ID: 15454951
[TBL] [Abstract][Full Text] [Related]
6. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
Blesch A
Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
[TBL] [Abstract][Full Text] [Related]
8. A heterologous system for assembly of retroviral gene vectors: intracellular budding in yeast?
Tolmachov O
Med Hypotheses; 2006; 67(4):807-9. PubMed ID: 16759811
[TBL] [Abstract][Full Text] [Related]
9. Surface-engineering of lentiviral vectors.
Verhoeyen E; Cosset FL
J Gene Med; 2004 Feb; 6 Suppl 1():S83-94. PubMed ID: 14978753
[TBL] [Abstract][Full Text] [Related]
10. The US and EU regulatory perspectives on the clinical use of hematopoietic stem/progenitor cells genetically modified ex vivo by retroviral vectors.
Wilson CA; Cichutek K
Methods Mol Biol; 2009; 506():477-88. PubMed ID: 19110646
[TBL] [Abstract][Full Text] [Related]
11. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.
Van Damme A; Chuah MK; Collen D; VandenDriessche T
Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930
[TBL] [Abstract][Full Text] [Related]
12. [Retroviral vectors in gene therapy].
Prasolov VS; Ivanov DS
Vopr Med Khim; 2000; 46(3):207-25. PubMed ID: 11033882
[TBL] [Abstract][Full Text] [Related]
13. Effects of cell cycle status on early events in retroviral replication.
Katz RA; Greger JG; Skalka AM
J Cell Biochem; 2005 Apr; 94(5):880-9. PubMed ID: 15669021
[TBL] [Abstract][Full Text] [Related]
14. Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.
Ghani K; Cottin S; Kamen A; Caruso M
Gene Ther; 2007 Dec; 14(24):1705-11. PubMed ID: 17928873
[TBL] [Abstract][Full Text] [Related]
15. State-of-the-art of the production of retroviral vectors.
Merten OW
J Gene Med; 2004 Feb; 6 Suppl 1():S105-24. PubMed ID: 14978755
[TBL] [Abstract][Full Text] [Related]
16. Effect of medium sugar source on the production of retroviral vectors for gene therapy.
Coroadinha AS; Ribeiro J; Roldão A; Cruz PE; Alves PM; Merten OW; Carrondo MJ
Biotechnol Bioeng; 2006 May; 94(1):24-36. PubMed ID: 16514678
[TBL] [Abstract][Full Text] [Related]
17. Retrovirus vectors: toward the plentivirus?
Baum C; Schambach A; Bohne J; Galla M
Mol Ther; 2006 Jun; 13(6):1050-63. PubMed ID: 16632409
[TBL] [Abstract][Full Text] [Related]
18. Purification of retroviral vectors for clinical application: biological implications and technological challenges.
Rodrigues T; Carrondo MJ; Alves PM; Cruz PE
J Biotechnol; 2007 Jan; 127(3):520-41. PubMed ID: 16950534
[TBL] [Abstract][Full Text] [Related]
19. Downstream processing of oncoretroviral and lentiviral gene therapy vectors.
Segura MM; Kamen A; Garnier A
Biotechnol Adv; 2006; 24(3):321-37. PubMed ID: 16448798
[TBL] [Abstract][Full Text] [Related]
20. Retroviral bicistronic vectors.
Pfützner W
Drug News Perspect; 2008 Nov; 21(9):473-80. PubMed ID: 19180265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
